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Abstract
Background: Bacterial meningitis (BM) is a severe infection responsible for high mortality and disabling sequelae.
Early identification of patients at high risk of these outcomes is necessary to prevent their occurrence by adequate
treatment as much as possible. For this reason, several prognostic models have been developed. The objective of
this study is to summarize the evidence regarding prognostic factors predicting death or sequelae due to BM in
children 0-18 years of age.
Methods: A search in MEDLINE and EMBASE was conducted to identify prognostic studies on risk factors for
mortality and sequelae after BM in children. Selection of abstracts, full-text articles and assessment of
methodological quality using the QUIPS checklist was performed by two reviewers independently. Data on
prognostic factors per outcome were summarized.
Results: Of the 31 studies identified, 15 were of moderate to high quality. Due to substantial heterogeneity in
study characteristics and evaluated prognostic factors, no quantitative analysis was performed. Prognostic factors
found to be statistically significant in more than one study of moderate or high quality are: complaints >48 hours
before admission, coma/impaired consciousness, (prolonged duration of) seizures, (prolonged) fever, shock,
peripheral circulatory failure, respiratory distress, absence of petechiae, causative pathogen Streptococcus
pneumoniae, young age, male gender, several cerebrospinal fluid (CSF) parameters and white blood cell (WBC)
count.
Conclusions: Although several important prognostic factors for the prediction of mortality or sequelae after BM
were identified, the inability to perform a pooled analysis makes the exact (independent) predictive value of these
factors uncertain. This emphasizes the need for additional well-conducted prognostic studies.
Background
Bacterial meningitis (BM) is a severe infection of the
central nervous system which occurs especially in chil-
dren <5 years of age. Although the occurrence of nega-
tive consequences of BM in developed countries is
strongly reduced by vaccination strategies, antibiotic
treatment and good care facilities, BM is still responsible
for substantial morbidity and mortality in both develop-
ing and developed countries [1-3].
The mortality rate is approximately 5%, and the long-
term morbidity, mainly consisting of persistent
neurological sequelae, is 15% [2,4-6]. Sensorineural hear-
ing loss, seizures, motor problems, hydrocephalus and
mental retardation [4,7-10], as well as more subtle out-
comes like cognitive, academic and behavioral problems
are observed in post-meningitis children [5,11].
I np e d i a t r i cc a r e ,t h eg o a lm u s tb et op r e v e n tt h e s e
sequelae as much as possible. Therefore, early recogni-
tion of children with BM with high risk for the develop-
ment of sequelae is mandatory [5,12-15]. For this
reason, several studies have developed prediction models
or have proposed prognostic factors for mortality or
morbidity in children after BM [5-9,12-37]. The aim of
the present study was to systematically review the avail-
able evidence regarding prognostic factors predicting * Correspondence: r.c.dejonge@amc.nl
1VU University Medical Center, Department of Pediatrics and Infectious
Diseases, Amsterdam, The Netherlands
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in both developing and developed countries.
Methods
Literature selection
A systematic search of MEDLINE and EMBASE until
March 20
th 2009 was conducted to identify prognostic
studies on mortality or various sequelae after BM in
children. The search focused on BM using terms for the
10 most common causative pathogens according to the
Netherlands Reference Laboratory for Bacterial Meningi-
tis [38]. These pathogens are listed in Apendix 1. Tuber-
culoid meningitis or rare forms of BM were excluded.
The search was refined using MeSH terms and text
words on: morbidity, mortality, cause of death, survival
rate, survival, prognos*, predict*, course*, cohort* longitu-
dinal, cohort studies, follow-up, followup, follow up, fol-
low-up studies. The search strategies used for Medline
and Embase are included in Appendix 2. All abstracts
found were screened by two reviewers independently
(RdJ and MW). Those potentially eligible for inclusion
were read in full text by the same two reviewers inde-
pendently and subsequently discussed during a consen-
sus meeting. Reference lists of each of the selected
publications were checked to retrieve relevant
publications which had not been identified by the com-
puterized search.
The publications had to meet the following inclusion
criteria, which were defined prior to the search:
- The study aimed to identify prognostic factors on
mortality or various sequelae due to BM. Only studies
designed as prognosis studies were included. Studies
designed to analyze an associative model were excluded.
- The study was designed as a longitudinal cohort
study, with at least one follow-up measurement. Both
prospective and retrospective studies were included.
- BM had occurred at 0-18 years of age.
- Results were published in English as full report arti-




The assessment of the methodological quality was per-
formed using the Quality In Prognosis Studies (QUIPS)
tool, designed for systematic reviews of prognostic stu-
dies through international expert consensus (Table 1)
[39]. This assessment was performed independently by
two authors (RdJ and MW). Disagreements between
both authors were discussed during a consensus
meeting.




￿ Target population 3 1.5 0
￿ Sampling frame 3 1.5 0
￿ Inclusion criteria 3 1.5 0
￿ Baseline study population 3 1.5 0
￿ Adequate study participation 3 1.5 0
2. Study attrition
￿ Proportion of population available for analysis 5 2.5 0
￿ Outcome and prognostic factor information on those lost to follow up 5 2.5 0
￿ Reasons and potential impact of subjects lost to follow up 5 2.5 0
3. Measurement of prognostic factors
￿ Definition of prognostic factor 5 2.5 0
￿ Valid and reliable measurement of prognostic factor 5 2.5 0
￿ Method and setting of prognostic factor measurement 5 2.5 0
4. Measurement of outcomes
￿ Definition of outcome 5 2.5 0
￿ Valid and reliable measurement of outcome 5 2.5 0
￿ Method and setting of outcome measurement 5 2.5 0
5. Statistical analysis and presentation
￿ Presentation of analytical strategy 5 2.5 0
￿ Model development strategy 5 2.5 0
￿ Reporting of results 5 2.5 0
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Page 2 of 14The QUIPS contains six categories assessing (1) bias
due to patient selection, (2) attrition, (3) measurement
of prognostic factors, (4) outcome measurement, (5)
confounding on statistical analysis, and (6) confounding
on presentation. The items on confounding were con-
sidered irrelevant for our study because in studies
regarding prognosis, the design to predict a specific out-
come based on a combination of several possible prog-
nostic factors, confounding is not an issue. The
remaining 17 items of the five categories were each
scored to assess the quality of the included study. High
quality (‘+’) was scored when there was low risk of bias,
moderate quality (‘+/-’) with moderate risk, and low
quality (‘-’) when there was high risk of bias.
To strengthen the discriminative capacity of the
QUIPS we developed a scoring algorithm. All five cate-
gories were given a maximum of 15 points each, equally
divided over all items per category. For all items we
assigned 5 points in case of low risk of bias and 2.5 and
0 in case of moderate and high risk of bias, respectively.
Except for category 1 (patient selection bias) which con-
tained five instead of three items. Here we assigned 3
points in case of low risk of bias and 1.5 and 0 in case
of moderate and high risk of bias, respectively. A total
score, with a maximum of 75 points, was calculated by
summing up the scores per item. A priori, we chose to
consider ≥60 points (≥80% of the maximum attainable
score) as high quality, between 45 and 60 points (≥60%
of the maximum attainable score) as moderate/high
quality and <45 points as low quality studies.
Data extraction and analysis
Of the selected studies, data were extracted regarding
study population (age at infection, country), causative
pathogen, design (prospective or retrospective), duration
of follow-up, method of analysis (uni- or multivariate),
outcome measures and independent statistically signifi-
cant prognostic factors from multivariate analysis or, if
not available, from univariate analysis (p < 0.05). To
facilitate interpretation and comparison of the results,
data were categorized per outcome: (1) hearing loss, (2)
mortality, (3) neurological sequelae, or (4) poor outcome
when the original study made no distinction between
mortality and neurological sequelae. Both short- and
long-term outcomes were included.
This review did not aim to analyze original study data,
therefore only the data presented in the manuscripts
was used. Authors were not approached for insight in
their data.
Analysis of prognostic factors
Due to heterogeneity in study design, study population
and analyses of the included studies, no quantitative analy-
sis was performed. Instead, the prognostic factors
predictive for mortality or sequelae after BM were sum-
marized per outcome category. Prognostic factors reported
in different papers on the same cohort were counted once.
Due to the large variety in proposed factors found, only
those factors found significant (p < 0.05) in more than one
study of moderate/high quality were presented.
Results
Selection of studies
Figure 1 presents a flow chart of the study selection.
The search strategy yielded 6,963 citations. Of these, 43
articles seemed to fulfill the inclusion criteria and were
retrieved in full text. Two additional articles were identi-
fied by checking the reference lists. Review of these 45
articles resulted in exclusion of 14 articles not meeting
the inclusion criteria. Eleven studies were excluded
based on design (one letter, one validation study and
nine presenting an association model instead of a prog-
nostic model), one study dealt with diagnosis (prediction
of meningitis instead of sequelae), and two studies were
excluded because no differentiation was made between
viral or aseptic and BM for outcome measurement.
Finally, 31 articles were included and assessed on meth-
odological quality.
Methodological quality
T h er e s u l t so ft h eq u a l i t ya s s essment are presented in
Table 2. The overall quality score ranged from 17 to
Abstracts retrieved from MEDLINE
(N =2855) and EMBASE (N =4108)
(N = 6963) 
Potential relevant articles, retrieved 
in full text for evaluation
(N = 43) 
Irrelevant abstracts excluded
(N = 6920) 
Excluded not meeting inclusion 
criteria (N = 14) 
Articles retrieved for quality 
assessment and included for analysis 
(N = 31) 
Reference checking, two extra 
articles (N = 2), 
total articles N = 45
Figure 1 Selection and number of publications.
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Page 3 of 1462.5 points with a median score of 43.5. Based on our
cutoff of ≥60 and ≥45 points, respectively, one article
was classified as high quality, 14 articles were classified
as moderate/high quality and 16 articles as low quality
studies.
Studies of moderate/high quality scored well on
patient selection, outcome measurement, statistical ana-
lysis and presentation, and relatively well on prognostic
factor measurement. However, many moderate/high
quality studies scored poor on attrition. Studies classi-
fied as low quality scored relatively well on patient
selection, but poor on all other categories. A poor score
on prognostic factor measurement was often due to the
fact the studies did not mention all factors considered
in their analysis but presented only those factors found
significant.
Study characteristics
Table 3 summarizes the study characteristics of all
included publications. Studies were grouped by outcome
categories and ranked by quality. Of all 31 included stu-
dies, four studies focused on hearing loss, four on mor-
tality, five on neurological sequelae ranging from mild
to severe, and another 12 studies focused on poor out-
come. The remaining six studies focused on both mor-
tality and neurological sequelae, for which results were
presented separately. Therefore, these studies were
included more than once. The majority of all studies
(n = 21) had a retrospective study design and 22 were
conducted in developed countries. Sixteen studies per-
formed a multivariate analysis. Although Klinger et al.
[31] performed a multivariate analysis, we reported the
prognostic factors based on their univariate analysis,



















Koomen et al., 2004 [5] 15 12.5 10 12.5 12.5 62.5 +
Lovera et al., 2005 [33] 13.5 7.5 12.5 10 12.5 56 +/-
Roine et al., 2008 [35] 15 10 7.5 7.5 15 55 +/-
Oostenbrink et al., 2002 [21] 15 7.5 10 10 12.5 55 +/-
Pelkonen et al., 2009 [6] 12 10 12.5 7.5 12.5 54.5 +/-
Forsyth et al., 2004 [18] 10.5 10 7.5 15 10 53 +/-
Biesheuvel et al., 2006 [24] 12 7.5 10 10 12.5 52 +/-
Pagliano et al., 2007 [19] 12 5 12.5 10 12.5 52 +/-
Koomen et al., 2003 [7] 15 7.5 10 7.5 10 50 +/-
Woolley et al., 1999 [9] 12 5 7.5 12.5 12.5 49.5 +/-
Klinger et al., 2000 [31] 13.5 7.5 7.5 10 10 48.5 +/-
Singhi et al., 2007 [15] 13.5 5 5 12.5 12.5 48.5 +/-
Kornelisse et al., 1995 [8] 10.5 5 10 10 12.5 48 +/-
Fakhir et al., 1992 [27] 12 7.5 7.5 12.5 7.5 47 +/-
Akpede et al., 1999 [16] 10.5 7.5 10 10 7.5 45.5 +/-
Kaaresen et al., 1995 [29] 13.5 7.5 7.5 5 10 43.5 -
Kutz et al., 2006 [14] 13.5 5 7.5 7.5 10 43.5 -
Pikis et al., 1996 [20] 13.5 7.5 7.5 7.5 7.5 43.5 -
Pomeroy et al., 1990 [34] 15 5 5 10 7.5 42.5 -
Wasier et al., 2005 [37] 10.5 5 7.5 7.5 10 40.5 -
Grimwood et al., 1996 [12] 7.5 5 7.5 12.5 7.5 40 -
Edwards et al., 1985 [17] 10.5 7.5 7.5 10 2.5 38 -
Letson et al., 1992 [32] 10.5 5 5 10 7.5 38 -
Chao et al., 2008 [26] 12 2.5 5 7.5 5 32 -
Johnson et al. 2007 [28] 12 2.5 5 7.5 5 32 -
Bortolussi et al., 1978 [25] 10.5 5 2.5 7.5 5 30.5 -
Antilla et al., 1994 [22] 7.5 2.5 7.5 7.5 2.5 27.5 -
Kirimi et al., 2003 [30] 7.5 5 7.5 2.5 5 27.5 -
Valmari et al., 1987 [36] 4.5 2.5 5 5 7.5 24.5 -
Herson et al., 1977 [13] 4.5 2.5 5 2.5 5 19.5 -
Bhat et al., 1987 [23] 4.5 2.5 2.5 2.5 5 17 -
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Page 9 of 14since this study reported several models for different
time intervals which was more difficult to compare with
other results. There was considerable variation among
studies with respect to population size (37 - 716
patients) and follow-up duration (from moment of hos-
pital discharge up to 23 years later). Studies also varied
with respect to age at infection (0-17, of which three
studies considered specifically neonatal/infant age) and
type of causative pathogen studied (varying from
describing all types (n = 17), to those only studying a
specific microorganism (n = 9; mainly Streptococcus
pneumoniae)) or more than one but not all microorgan-
isms (n = 5; mainly concerning all microorganisms;
however, excluding Haemophilus influenzae type B
(HiB)).
Prognostic factors
Table 4 summarizes the most important prognostic fac-
tors for sequelae and death after BM per type of out-
come. For mortality and various sequelae together, 75
different possible prognostic factors were identified as
significant by the included studies. Many of these factors
might be of influence for the prediction of sequelae.
However, it is implausible that all of them will be
(equally) important. And due to poor study quality, fac-
tors not predictive for sequelae or death might have
been found as prognostic factors. We therefore consid-
ered only those factors found significant in more than
one study of moderate/high quality as evidence for
being potentially important factors. Results from uni-
variate and multivariate analyses are presented
Table 4 Summary of prognostic factors.
Prognostic factor Moderate/high quality studies with
multivariate analysis































2x 2x 2x 1x 4x 1x 3x 1x 6x
Seizures 1x 2x 2x 2x 1x 2x 2x 4x
Shock/
hypotension
3x 1x 2x 3x
Peripheral
circulatory failure












2x 1x 3x 1x 2x 2x 3x
Low CSF WBC
count
1x 1x 1x 1x 1x 2x 3x
Low CSF glucose
level
2x 1x 1x 1x 1x 2x 6x
High CSF protein
level





Young age 1x 1x 2x 1x 1x
<1
years




Male gender 1x 1x 1x 2x
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Page 10 of 14separately. Factors reported in studies of low quality are
reported combined and not per type of outcome.
In total, 17 factors were regarded as showing some
evidence of importance in the prediction of sequelae or
mortality after BM.
- For hearing loss, the factors S. pneumoniae as a
causative pathogen and a low cerebrospinal fluid
( C S F )g l u c o s el e v e ls h o w e ds o m ee v i d e n c eo fb e i n g
important (i.e. reported in more than one moderate/
high quality study).
- For mortality, coma and seizures were found to be
predictive, next to shock, peripheral circulatory fail-
ure, severe respiratory distress, a low peripheral
white blood cell (WBC) count and a high CSF pro-
tein level.
- For neurological sequelae in general, coma, sei-
zures, prolonged fever for at least seven days and a
low CSF (WBC) count were considered important
risk factors.
Studies reporting on poor outcome, and thereby not
differentiating between sequelae or mortality, also
reported coma, seizures, shock, a low WBC count both
peripheral as well as in CSF and a low CSF glucose level
and a high CSF protein level to be important risk fac-
tors. Yet they also identified young age (indicated as
younger than two years old) and prolonged seizure
duration (>12 hours after admission) as important prog-
nostic factors.
When considering all moderate/high quality studies
combined, the factors of history of symptoms longer
than 48 hours, male gender, fever and absence of pete-
chiae were also found more than once. Although these
factors have not been found in more than one study of
moderate/high quality for a specific outcome category,
they may be important prognostic factors for sequelae
or mortality in general.
The 17 identified risk factors were also found in sev-
eral studies of low quality (see last column of Table 4).
Discussion
We identified 31 studies in the literature on prognostic
factors predicting sequelae or death due to BM in
children 0-18 years of age. The included studies have
presented a large number of potentially important prog-
nostic factors. Only those factors reported in more than
one moderate/high quality study were considered as
showing some evidence of being important. These fac-
tors included several clinical parameters: coma/impaired
consciousness, seizures, shock, peripheral circulatory
failure, severe respiratory distress, (prolonged) fever and
prolonged duration of seizures, which are all signs of
severity during the acute phase of the disease. In addi-
tion, the presented factors also included results from
diagnostic tests which are performed during admission
of the patient in the hospital: low peripheral WBC and
low WBC count in CSF, low CSF glucose level and high
CSF protein level. These factors are indicators of an
acute severe CNS infection and thus are also parameters
of severity of the disease.
The presence of these clinical and diagnostic factors in
our study demonstrates that severe illness at admission
contributes to BM-related mortality and long-term
sequelae. In addition, young age was also considered an
important prognostic factor. This might be explained by
the immature immune status resulting in more severe
infections (especially in neonates and children younger
than six months) and the developing (and thus more
vulnerable) brain of young children. Although it is
thought that young children have a higher capability of
neurogenesis than older children and adults which leads
to better structural repair of brain tissue, and it is
known they have a higher plasticity of the brain that
allows intact parts to take over functions of damaged
areas, early disruption of the developing brain may leads
to more functional damage [40-43]. Further, sequelae of
meningitis like epilepsy, cerebral palsy and hearing pro-
blems can independently cause developmental problems
in the young child.
Another prognostic factor which we also demon-
strated to be related to severity was the causative patho-
gen of BM. S. pneumoniae seemed to be an important
prognostic factor, suggesting a more pathogenic potency
of this species in comparison to other bacteria. This has
also been found in other studies presenting association
or prognostic models in children or adults [3,10,44]. We
also found the absence of petechiae to be a prognostic
factor. Since petechiae are strongly related with the cau-
sative pathogen (occurring mostly in Neisseria meningi-
tidis infections, and much less in S. pneumoniae
meningitis), it supports the finding that S. pneumoniae
is responsible for a non favorable outcome. In studies of
high and moderate quality that reported the absence of
petechiae as a risk factor, S. pneumoniae was also a
prognostic factor of importance. Finally, male gender
was found as an important prognostic factor, for which
we do not have an explanation. All of these factors
might be important to assess in children with BM when
trying to identify those at the highest risk for the devel-
opment of sequelae.
The main concern about the interpretation of the
prognostic factors is the fact that due to limited quality
of the included studies and heterogeneity of the data it
is impossible to perform a meta-analysis and to con-
struct an overall prediction model.
de Jonge et al. BMC Infectious Diseases 2010, 10:232
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Page 11 of 14Limitations
The search strategy was restricted to full report articles
published in English, in journals available in the used
electronic databases. This might have led to language or
publication bias by missing relevant studies.
The quality of studies was assessed using the QUIPS
instrument, designed for prognosis studies addressing all
common sources of bias. The QUIPS, however, lacks
discriminative power. We defined a scoring algorithm
for better discrimination of study quality. This scoring
algorithm and cutoff points used to qualify the quality
of the studies are quite arbitrary. However, all identified
prognostic factors found in the included studies are pre-
sented in Table 3, allowing readers to draw their own
conclusions.
We encountered some problems in interpreting the
results of the studies. Only significant prognostic factors
of the original studies were presented in our review.
However, lack of statistical significance may be due to
lack of power. Furthermore, many studies performed
only univariate analysis and the presented factors might
not have been found significant if multivariate analysis
had been performed.
In our overview of prognostic factors we only strati-
fied per type of outcome. We did not compare other
subgroups, thereby ignoring the heterogeneity in all
other study characteristics (study design, method of ana-
lysis, follow-up duration, population, age at infection,
pathogen and country of study). We refrained from this
since strata would include too few studies of moderate/
high quality and too many prognostic factors to discri-
minate between the groups and draw reliable
conclusions.
Finally, due to the limited quality of most studies, and
the heterogeneous nature of study characteristics and
r e s u l t s ,t h ef a c t o r sf o u n dm u s to n l yb eu s e dw i t h
caution.
Conclusions
Several plausible and important prognostic factors for
the prediction of sequelae or mortality after BM in
childhood were proposed. Because of the limited quality
of most studies and the heterogeneous nature of study
characteristics and results, findings must be interpreted
critically and the prognostic factors found may be used
only with caution. This demonstrates that more high
quality prognostic studies on factors related to sequelae
or death after BM in childhood are clearly needed.
Appendix 1
The 10 most common causative pathogens of BM




-Haemophilus influenzae type B (HiB)
-Listeria monocytogenes
-Escherichia coli





Appendix 2: used search strategies for Medline
and Embase
Medline
#1 search terms on “Bacterial meningitis”
“Meningitis, Bacterial"[Mh] OR “Meningitis, Bacterial/
complications"[Mh] OR “Meningitis, Bacterial/diagno-
sis"[Mh] OR “Meningitis, Bacterial/epidemiology"[Mh]
OR “Meningitis, Bacterial/physiopathology"[Mh] OR
“Meningitis, Bacterial/psychology"[Mh] OR “Meningitis,
Meningococcal"[Mh] OR “Meningitis, Meningococcal/
complications"[Mh] OR “Meningitis, Meningococcal/
diagnosis"[Mh] OR “Meningitis, Meningococcal/mortali-
ty"[Mh] OR “Meningitis, Pneumococcal"[Mh] OR
“Meningitis, Pneumococcal/complications"[Mh] OR
“Meningitis, Pneumococcal/diagnosis"[Mh] OR “Menin-
gitis, Pneumococcal/mortality"[Mh] OR “Meningitis,
Escherichia coli"[Mh] OR “Meningitis, Escherichia coli/
complications"[Mh] OR “Meningitis, Escherichia coli/
diagnosis"[Mh] OR “Meningitis, Escherichia coli/mortali-
ty"[Mh] OR “Meningitis, Haemophilus"[Mh] OR
“Meningitis, Haemophilus/complications"[Mh] OR
“Meningitis, Haemophilus/diagnosis"[Mh] OR “Meningi-
tis, Haemophilus/mortality"[Mh] OR “Meningitis, Lister-
ia"[Mh] OR “Meningitis, Listeria/complications"[Mh]
OR “Meningitis, Listeria/diagnosis"[Mh] OR “Meningitis,
Listeria/mortality"[Mh] OR meningitis[tw] AND (bacter-
ial[tw] OR meningococcal[tw] OR pneumococcal[tw]
OR Neisseria[tw] OR meningitides[tw] OR Streptococ-
cus[tw] OR pneumoniae[tw] OR Haemophilus[tw] OR
Hib[tw] OR influenzae[tw] OR Listeria[tw] OR monocy-
togenes[tw] OR Escherichia[tw] OR coli[tw] OR agalac-
tiae[tw] OR pyogenes[tw] OR Staphylococcus[tw] OR
aureus[tw] OR Cryptococcus[tw] OR neoformans[tw])
#2 search terms on “prognosis”
Morbidity[Mh:noexp] OR mortality[Mh:noexp] OR
“cause of death"[Mh] OR survival rate [Mh] OR prog-
nos*[tw] OR predict*[tw] OR course*[tw] OR longitudi-
nal[tw] OR follow-up[tw] OR followup[tw] OR follow
up[tw] OR cohort*[tw] OR survival[tw] OR cohort stu-
dies[mh] OR follow-up studies[mh]
#3 search terms exclusions
(“addresses”[Pt] OR “biography”[Pt] OR “case reports”[Pt]
OR “comment”[Pt] OR “directory”[Pt] OR “editorial”[Pt]
OR “festschrift”[Pt] OR “interview”[Pt] OR “lectures”[Pt]
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Page 12 of 14OR “legal cases”[Pt] OR “legislation”[Pt] OR “letter”[Pt]
OR “news”[Pt] OR “newspaper article”[Pt] OR “patient
education handout”[Pt] OR “popular works”[Pt] OR “con-
gresses”[Pt] OR “consensus development conference”[Pt]
OR “consensus development conference, nih”[Pt] OR
“practice guideline”[Pt]) NOT (“animals"[Mh Terms]
NOT “humans"[Mh Terms])
Final search on Bacterial meningitis and prognosis with
exclusions
#1 AND #2 NOT #3
Embase
#1 search terms on “Bacterial meningitis”
(((‘bacterial meningitis’/exp OR ‘bacterial meningitis’)O R
(‘epidemic meningitis’/exp OR ‘epidemic meningitis’)) OR
(‘meningitis’/de OR ‘meningitis’) AND (bacterial
OR meningococcal OR pneumococcal OR (‘neisseria’/de
OR ‘neisseria’)O Rm e n i n g i t i d e sO R( ‘streptococcus’/de
OR ‘streptococcus’)O Rp n e u m o n i a eO R( ‘haemophilus’/
de OR ‘haemophilus’) OR hib OR influenzae OR (‘listeria’/
de OR ‘listeria’) OR monocytogenes OR (‘escherichia’/de
OR ‘escherichia’) OR coli OR agalactiae OR pyogenes OR
(‘staphylococcus’/de OR ‘staphylococcus’) OR aureus OR
(‘cryptococcus’/de OR ‘cryptococcus’) OR neoformans)).
include text word
#2 search terms on “prognosis”
(((‘morbidity’/de OR ‘morbidity’)O R( ‘mortality’/de OR
‘mortality’)O R( ‘cause of death’/exp OR ‘cause of
death’)O R( ‘survival rate’/exp OR ‘survival rate’)O R
(‘cohort analysis’/exp OR ‘cohort analysis’)O R( ‘follow
up’/exp OR ‘follow up’)) OR prognos* OR predict* OR
course* OR cohort* OR longitudinal OR (‘follow up’/de
OR ‘follow up’)O R( ‘followup’/de OR ‘followup’)O R
(‘survival’/de OR ‘survival’)). include text word
#3 search terms exclusions
((‘literature’/exp OR ‘literature’/de) OR (‘case report’/exp
OR ‘case report’/de) OR (‘directory’/exp OR ‘directory’/
de) OR (‘editorial’/exp OR ‘editorial’/de) OR (‘interview’/
exp OR ‘interview’/de) OR (‘medicolegal aspect’/exp OR
‘medicolegal aspect’/de) OR (‘reading’/exp OR ‘reading’/
de) OR (‘publication’/exp OR ‘publication’/de) OR
(‘patient education’/exp OR ‘patient education’/de) OR
(‘organization’/exp OR ‘organization’/de) OR (‘consensus
development’/exp OR ‘consensus development’/de) OR
(‘practice guideline’/exp OR ‘practice guideline’/de))
NOT ((‘animal’/exp OR ‘animal’/de) NOT (‘human’/exp
OR ‘human’/de))
Final search Bacterial meningitis and prognosis with
exclusions
#1 AND #2 NOT #3
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